Clinical Trials Directory

Trials / Completed

CompletedNCT04840953

Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients

Status
Completed
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Background Numerous surgicals treatments have been described for the massive subcutaneous emphysema; however, some of these techniques cannot be carried out in a critical care unit and they are related with high morbidity and exposure in positive SARS COV-2 patients. More effective, less invasive and isolated procedures should be implemented. Technique Negative pressure therapy (NPT) that can allow effective solving of massive subcutaneous emphysema in a short period (5 days) with a minimally invasive approach at the bedside in Covid-19 or non infected critical patients. Conclusion NPT is an effective and low invasive strategy for the management of EES in critical patients with high risk of mortality.

Conditions

Interventions

TypeNameDescription
DEVICEVçacVAC THERAPY vs SURGICAL DREINAGE

Timeline

Start date
2020-12-01
Primary completion
2021-01-01
Completion
2021-02-01
First posted
2021-04-12
Last updated
2021-04-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04840953. Inclusion in this directory is not an endorsement.